RGC-1501 / ABVC BioPharma, Rgene Corp 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RGC-1501 / ABVC BioPharma, Rgene Corp
NCT05764928: Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Not yet recruiting
1/2
32
RoW
BLEX 404
Rgene Corporation, American BriVision Corporation
Nonsquamous Nonsmall Cell Neoplasm of Lung
12/26
12/26

Download Options